Email updates

Keep up to date with the latest news and content from HRJ and BioMed Central.

Open Access Commentary

Curbing the menace of antimicrobial resistance in developing countries

Chidi Victor Nweneka1*, Ndey Tapha-Sosseh2 and Anibal Sosa3

Author Affiliations

1 Medical Research Council Laboratories, Keneba Field Station, P.O. Box 273, Banjul, The Gambia

2 Alliance for the Prudent Use of Antibiotics, The Gambia, P.O. Box 3416, Serekunda, The Gambia

3 Alliance for the Prudent Use of Antibiotics (APUA), 75 Kneeland Street, Boston, MA 02111, USA

For all author emails, please log on.

Harm Reduction Journal 2009, 6:31  doi:10.1186/1477-7517-6-31

Published: 19 November 2009

Abstract

Several reports suggest that antimicrobial resistance is an increasing global problem; but like most pandemics, the greatest toll is in the less developed countries. The dismally low rate of discovery of antimicrobials compared to the rate of development of antimicrobial resistance places humanity on a very dangerous precipice. Since antimicrobial resistance is part of an organism's natural survival instinct, total eradication might be unachievable; however, it can be reduced to a level that it no longer poses a threat to humanity. While inappropriate antimicrobial consumption contributes to the development of antimicrobial resistance, other complex political, social, economic and biomedical factors are equally important. Tackling the menace therefore should go beyond the conventional sensitization of members of the public and occasional press releases to include a multi-sectoral intervention involving the formation of various alliances and partnerships. Involving civil society organisations like the media could greatly enhance the success of the interventions